Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone

Anna Mero, Monica Campisi, Michele Caputo, Christian Cuppari, Antonio Rosato, Oddone Schiavon, Gianfranco Pasut

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hyaluronic acid (HA) is a natural polysaccharide primarily present in the vitreous humor and in cartilages where it plays a key structural role in organizing the cartilage extracellular matrix. HA is used in a wide range of applications including treatment of arthritis (as a viscosupplementation agent for joints) and in a variety of cosmetic injectable products. Its safety profile is thus well established. Thanks to its high biocompatibility and targeting properties, HA has also been investigated for use as a carrier of anticancer drugs and, recently, also of proteins. Its role in the last case is a particularly challenging one as dedicated coupling chemistries are required to preserve the protein’s conformation and activity. This study focuses on the state of the art on protein HAylation. New data from our laboratory on the local delivery of specific biologics to joints will also be outlined.

Original languageEnglish
Article numberA011
Pages (from-to)1503-1511
Number of pages9
JournalCurrent Drug Targets
Volume16
Issue number13
Publication statusPublished - 2015

Fingerprint

Human Growth Hormone
Hyaluronic Acid
Carrier Proteins
Cartilage
Viscosupplementation
Joints
Vitreous Body
Protein Conformation
Drug Carriers
Proteins
Cosmetics
Biological Products
Biocompatibility
Arthritis
Extracellular Matrix
Polysaccharides
Conformations
Safety
Injections
Pharmaceutical Preparations

Keywords

  • Arthritis
  • Biopharmaceuticals
  • Human growth hormone
  • Hyaluronic acid
  • Polymer conjugation
  • Site-selective conjugation

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Mero, A., Campisi, M., Caputo, M., Cuppari, C., Rosato, A., Schiavon, O., & Pasut, G. (2015). Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone. Current Drug Targets, 16(13), 1503-1511. [A011].

Hyaluronic acid as a protein polymeric carrier : An overview and a report on human growth hormone. / Mero, Anna; Campisi, Monica; Caputo, Michele; Cuppari, Christian; Rosato, Antonio; Schiavon, Oddone; Pasut, Gianfranco.

In: Current Drug Targets, Vol. 16, No. 13, A011, 2015, p. 1503-1511.

Research output: Contribution to journalArticle

Mero, A, Campisi, M, Caputo, M, Cuppari, C, Rosato, A, Schiavon, O & Pasut, G 2015, 'Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone', Current Drug Targets, vol. 16, no. 13, A011, pp. 1503-1511.
Mero A, Campisi M, Caputo M, Cuppari C, Rosato A, Schiavon O et al. Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone. Current Drug Targets. 2015;16(13):1503-1511. A011.
Mero, Anna ; Campisi, Monica ; Caputo, Michele ; Cuppari, Christian ; Rosato, Antonio ; Schiavon, Oddone ; Pasut, Gianfranco. / Hyaluronic acid as a protein polymeric carrier : An overview and a report on human growth hormone. In: Current Drug Targets. 2015 ; Vol. 16, No. 13. pp. 1503-1511.
@article{5f83cf9f1e2d49d68279636a93509962,
title = "Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone",
abstract = "Hyaluronic acid (HA) is a natural polysaccharide primarily present in the vitreous humor and in cartilages where it plays a key structural role in organizing the cartilage extracellular matrix. HA is used in a wide range of applications including treatment of arthritis (as a viscosupplementation agent for joints) and in a variety of cosmetic injectable products. Its safety profile is thus well established. Thanks to its high biocompatibility and targeting properties, HA has also been investigated for use as a carrier of anticancer drugs and, recently, also of proteins. Its role in the last case is a particularly challenging one as dedicated coupling chemistries are required to preserve the protein’s conformation and activity. This study focuses on the state of the art on protein HAylation. New data from our laboratory on the local delivery of specific biologics to joints will also be outlined.",
keywords = "Arthritis, Biopharmaceuticals, Human growth hormone, Hyaluronic acid, Polymer conjugation, Site-selective conjugation",
author = "Anna Mero and Monica Campisi and Michele Caputo and Christian Cuppari and Antonio Rosato and Oddone Schiavon and Gianfranco Pasut",
year = "2015",
language = "English",
volume = "16",
pages = "1503--1511",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "13",

}

TY - JOUR

T1 - Hyaluronic acid as a protein polymeric carrier

T2 - An overview and a report on human growth hormone

AU - Mero, Anna

AU - Campisi, Monica

AU - Caputo, Michele

AU - Cuppari, Christian

AU - Rosato, Antonio

AU - Schiavon, Oddone

AU - Pasut, Gianfranco

PY - 2015

Y1 - 2015

N2 - Hyaluronic acid (HA) is a natural polysaccharide primarily present in the vitreous humor and in cartilages where it plays a key structural role in organizing the cartilage extracellular matrix. HA is used in a wide range of applications including treatment of arthritis (as a viscosupplementation agent for joints) and in a variety of cosmetic injectable products. Its safety profile is thus well established. Thanks to its high biocompatibility and targeting properties, HA has also been investigated for use as a carrier of anticancer drugs and, recently, also of proteins. Its role in the last case is a particularly challenging one as dedicated coupling chemistries are required to preserve the protein’s conformation and activity. This study focuses on the state of the art on protein HAylation. New data from our laboratory on the local delivery of specific biologics to joints will also be outlined.

AB - Hyaluronic acid (HA) is a natural polysaccharide primarily present in the vitreous humor and in cartilages where it plays a key structural role in organizing the cartilage extracellular matrix. HA is used in a wide range of applications including treatment of arthritis (as a viscosupplementation agent for joints) and in a variety of cosmetic injectable products. Its safety profile is thus well established. Thanks to its high biocompatibility and targeting properties, HA has also been investigated for use as a carrier of anticancer drugs and, recently, also of proteins. Its role in the last case is a particularly challenging one as dedicated coupling chemistries are required to preserve the protein’s conformation and activity. This study focuses on the state of the art on protein HAylation. New data from our laboratory on the local delivery of specific biologics to joints will also be outlined.

KW - Arthritis

KW - Biopharmaceuticals

KW - Human growth hormone

KW - Hyaluronic acid

KW - Polymer conjugation

KW - Site-selective conjugation

UR - http://www.scopus.com/inward/record.url?scp=84946406028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946406028&partnerID=8YFLogxK

M3 - Article

C2 - 25563593

AN - SCOPUS:84946406028

VL - 16

SP - 1503

EP - 1511

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 13

M1 - A011

ER -